Prolongation of Mysimba® distribution agreement Publisert: 20.10.2026 Navamedic launches Virono®– the first single-dose over-the-counter cold sore tablet Publisert: 21.05.2026 Navamedic ASA: Notice of Annual General Meeting Publisert: 31.03.2026 Grete Roede og Navamedic lanserer nytt vektreduksjonskonsept: Lettere steg Publisert: 29.12.2025 Oslo, December 9, 2025 – Navamedic ASA Introduces Flexilev[®] in OraFID[®]: Enhancing Parkinson’s Care with Simplified and Precise Dosing for Personalized Treatment Publisert: 09.12.2025 Ny svensk Novusundersökning: Så vanligt är känslomässigt ätande vid övervikt Publisert: 03.12.2025 FørsteForrige12345NesteSiste
Navamedic launches Virono®– the first single-dose over-the-counter cold sore tablet Publisert: 21.05.2026
Oslo, December 9, 2025 – Navamedic ASA Introduces Flexilev[®] in OraFID[®]: Enhancing Parkinson’s Care with Simplified and Precise Dosing for Personalized Treatment Publisert: 09.12.2025